225 results on '"Miravitlles, Marc"'
Search Results
2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
3. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
4. The Natural History of Severe Chronic Obstructive Pulmonary Disease: The SPOCCAT Study Protocol
5. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)
6. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
7. Potential systemic effects of acquired CFTR dysfunction in COPD
8. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
9. Poor sleep is associated with deficits of attention in COPD patients
10. Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia
11. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
12. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study
13. Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease
14. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
15. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
16. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach
17. Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
18. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
19. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
20. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
21. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
22. Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care
23. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
24. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
25. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
26. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
27. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
28. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
29. Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study
30. Conocimiento de la enfermedad pulmonar obstructiva crónica, presencia de síntomas respiratorios crónicos y uso de la espirometría en la población española: estudio CONOCEPOC 2019
31. miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease
32. miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease
33. HLA-DRB1 Alleles are Associated With COPD in a Latin American Admixed Population
34. HLA-DRB1 Alleles are Associated With COPD in a Latin American Admixed Population
35. Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain
36. Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain
37. Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study
38. Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study
39. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency
40. Prevalence and Determinants of COPD in Spain: EPISCAN II
41. Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study
42. Prevalence and Determinants of COPD in Spain: EPISCAN II
43. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency
44. Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study
45. Sex differences between women and men with COPD: A new analysis of the 3CIA study
46. Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers
47. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap
48. Características clínicas y riesgo de agudizaciones asociados con diferentes criterios diagnósticos del solapamiento asma-EPOC
49. Evaluation of Changes in Control Status in COPD: An Opportunity for Early Intervention
50. Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.